StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.23−0.03 (-10.27%)

Close on Nov 17, 2026Market cap $3.59MP/E –Yield –

Traws Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Traws Pharma's price to sales ratio was 4.6× on Apr 30, 2026, against 23.4× a year earlier. Over the last 5 years it ranged from 2.8× to 465.3×, with a median of 69.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20264.6×+1.8
2025Dec 31, 20252.8×−116.0
2024Dec 31, 2024118.9×+49.6
2023Dec 29, 202369.3×+9.1
2022Dec 30, 202260.2×−174.5
2021Dec 31, 2021234.7×−190.5
2020Dec 31, 2020425.2×+423.8
2019Dec 31, 20191.4×−7.7
2018Dec 31, 20189.1×−9.0
2017Dec 29, 201718.1×+17.1
2016Dec 30, 20161.0×−10.5
2015Dec 31, 201511.5×−15.8
2014Dec 31, 201427.3×−15.2
2013Dec 31, 201342.5×–

More Traws Pharma figures

See a number that looks wrong?